stock
Alnylam Pharmaceuticals Inc
NASDAQ | ALNY
391.50
USD
$0.00
(0.00%
)At Close (As of Dec 15, 2025)
$52.52B
Market Cap
1242.34
P/E Ratio
0.32
EPS
$495.55
52 Week High
$205.87
52 Week Low
HEALTHCARE
Sector
ALNY Chart
Recent Chart
Price Action
ALNY Technicals
ALNY Earnings
Earnings Performance
ALNY Financials
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$8.3M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $57M |
| Capital Expenditures | $34M |
| Change In Receivables | - |
| Change In Inventory | $14M |
| Profit Loss | - |
| Cashflow From Investment | -$117M |
| Cashflow From Financing | $294M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$278M |
ALNY News
ALNY Profile
Alnylam Pharmaceuticals Inc Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Alnylam Pharmaceuticals, Inc., based in Cambridge, Massachusetts, is a leading biopharmaceutical company that specializes in RNA interference (RNAi) therapeutics to combat genetic diseases. With a strong focus on innovation, Alnylam has developed a diverse pipeline of RNAi-based therapies and achieved commercial success with its first product launch. The company's commitment to scientific advancement and addressing unmet medical needs positions it at the forefront of the biopharmaceutical industry, as it seeks to transform treatment approaches for both rare and common conditions. Alnylam's dedication to research and development underscores its role as a key player in redefining the future of medicine.
LPTX +368.57%
$2.05
WOK -40.00%
$0.06
MASK +36.34%
$0.41
OCG -21.36%
$0.17
NVDA +0.72%
$176.29
YGMZ -61.42%
$0.02
TSLA +3.56%
$475.31
ASST -8.57%
$0.78
PAVS -11.67%
$0.03
IRBT -72.68%
$1.18
CGC -4.59%
$1.66
ONDS -12.11%
$7.69
AMCI
+168.26%
$7.27
PLUG -4.31%
$2.22
AAL +2.47%
$15.33
MIST -2.69%
$2.34
AXDX -61.36%
$0.03
YCBD 0.00%
$1.20
ASBP +13.05%
$0.10
AVGO -5.59%
$339.81
RIVN +1.52%
$18.70
BMNR
-11.21%
$30.95
IVP +13.54%
$0.05
PFE +2.24%
$26.43
LAZR -60.82%
$0.35
INTC -0.79%
$37.51
BITF -7.66%
$2.53
GRAB -2.52%
$5.02
BYND -4.58%
$1.04
BMNU
-22.40%
$6.44
F -0.79%
$13.65
WBD -0.90%
$29.71
ADAP -15.14%
$0.05
AAPL -1.49%
$274.11
SOFI -5.35%
$25.82
CIFR -13.54%
$14.74
ARTV +90.90%
$6.30
IREN -11.58%
$35.48
KVUE -0.69%
$17.21
AMZN -1.61%
$222.54
CLSK -15.07%
$11.91
MARA -7.11%
$10.70
PLTD +0.30%
$6.48
ORCL -2.65%
$184.92
APLD -17.51%
$22.98
SOND -23.45%
$0.12
SNAP -0.68%
$7.26
DNN -2.68%
$2.54
TLRY -10.04%
$10.93
RMBL +60.50%
$3.21
NFLX -1.49%
$93.77
LNW -3.71%
$86.22
ADD -25.47%
$0.05
T -1.09%
$24.31
WULF -12.84%
$12.49
ACHR -5.66%
$7.83
BTBT -8.00%
$2.07
SRM +53.27%
$10.30
RGTI -8.93%
$23.53
BTG +0.43%
$4.62
RKLB -9.88%
$55.41
VZ -0.22%
$40.80
PLTR -0.17%
$183.25
BAC +0.34%
$55.33
UBER -3.81%
$81.86
BBD +0.57%
$3.47
NIO -0.79%
$4.99
RIG -1.21%
$4.08
CRWV
-7.93%
$72.35
HPE +0.75%
$24.05
AMC -7.07%
$1.97
PFSA
-19.86%
$0.12
DVLT -7.24%
$1.28
QBTS -9.04%
$23.74
GOOGL -0.34%
$308.22
BURU
-1.12%
$0.20
HOOD -3.54%
$115.26
SOUN -7.38%
$10.79
CAN -6.13%
$0.78
AMD -1.51%
$207.58
ATPC -9.94%
$0.12
MU -1.50%
$237.50
PCG +1.31%
$15.36
MSTR -8.14%
$162.08
RR -14.56%
$3.52
HBAN -0.44%
$17.74
TWOH
0.00%
$0.00
IMG +6.17%
$1.72
AFMD -34.94%
$0.18
MSFT -0.77%
$474.82
URG +3.90%
$1.33
TE -5.42%
$5.06
VALE +0.63%
$12.77
CMG -0.55%
$35.94
VIVK -15.68%
$0.06
CLYM +27.00%
$3.81
IONQ -8.50%
$46.07
NCLH +3.78%
$21.65
GPUS
-5.19%
$0.24
BMY +3.58%
$54.29
LPTX +368.57%
$2.05
WOK -40.00%
$0.06
MASK +36.34%
$0.41
OCG -21.36%
$0.17
NVDA +0.72%
$176.29
YGMZ -61.42%
$0.02
TSLA +3.56%
$475.31
ASST -8.57%
$0.78
PAVS -11.67%
$0.03
IRBT -72.68%
$1.18
CGC -4.59%
$1.66
ONDS -12.11%
$7.69
AMCI
+168.26%
$7.27
PLUG -4.31%
$2.22
AAL +2.47%
$15.33
MIST -2.69%
$2.34
AXDX -61.36%
$0.03
YCBD 0.00%
$1.20
ASBP +13.05%
$0.10
AVGO -5.59%
$339.81
RIVN +1.52%
$18.70
BMNR
-11.21%
$30.95
IVP +13.54%
$0.05
PFE +2.24%
$26.43
LAZR -60.82%
$0.35
INTC -0.79%
$37.51
BITF -7.66%
$2.53
GRAB -2.52%
$5.02
BYND -4.58%
$1.04
BMNU
-22.40%
$6.44
F -0.79%
$13.65
WBD -0.90%
$29.71
ADAP -15.14%
$0.05
AAPL -1.49%
$274.11
SOFI -5.35%
$25.82
CIFR -13.54%
$14.74
ARTV +90.90%
$6.30
IREN -11.58%
$35.48
KVUE -0.69%
$17.21
AMZN -1.61%
$222.54
CLSK -15.07%
$11.91
MARA -7.11%
$10.70
PLTD +0.30%
$6.48
ORCL -2.65%
$184.92
APLD -17.51%
$22.98
SOND -23.45%
$0.12
SNAP -0.68%
$7.26
DNN -2.68%
$2.54
TLRY -10.04%
$10.93
RMBL +60.50%
$3.21
NFLX -1.49%
$93.77
LNW -3.71%
$86.22
ADD -25.47%
$0.05
T -1.09%
$24.31
WULF -12.84%
$12.49
ACHR -5.66%
$7.83
BTBT -8.00%
$2.07
SRM +53.27%
$10.30
RGTI -8.93%
$23.53
BTG +0.43%
$4.62
RKLB -9.88%
$55.41
VZ -0.22%
$40.80
PLTR -0.17%
$183.25
BAC +0.34%
$55.33
UBER -3.81%
$81.86
BBD +0.57%
$3.47
NIO -0.79%
$4.99
RIG -1.21%
$4.08
CRWV
-7.93%
$72.35
HPE +0.75%
$24.05
AMC -7.07%
$1.97
PFSA
-19.86%
$0.12
DVLT -7.24%
$1.28
QBTS -9.04%
$23.74
GOOGL -0.34%
$308.22
BURU
-1.12%
$0.20
HOOD -3.54%
$115.26
SOUN -7.38%
$10.79
CAN -6.13%
$0.78
AMD -1.51%
$207.58
ATPC -9.94%
$0.12
MU -1.50%
$237.50
PCG +1.31%
$15.36
MSTR -8.14%
$162.08
RR -14.56%
$3.52
HBAN -0.44%
$17.74
TWOH
0.00%
$0.00
IMG +6.17%
$1.72
AFMD -34.94%
$0.18
MSFT -0.77%
$474.82
URG +3.90%
$1.33
TE -5.42%
$5.06
VALE +0.63%
$12.77
CMG -0.55%
$35.94
VIVK -15.68%
$0.06
CLYM +27.00%
$3.81
IONQ -8.50%
$46.07
NCLH +3.78%
$21.65
GPUS
-5.19%
$0.24
BMY +3.58%
$54.29